USFDA approves Astellas' Veozah’ for treatment of vasomotor symptoms due to menopause

VEOZAH is first-in-class treatment option to reduce the frequency and severity of moderate to severe VMS due to menopause

AIIA and CCRAS jointly organised session for research and education in Ayush

Pandemic was the opportunity for Ayush to develop their science and Ayush did it by developing Ayush 64, etc

Boehringer Ingelheim begins clinical development for fibrotic diseases

‘Fibrotic disease’ is a term that covers a range of diseases characterized by uncontrolled and progressive fibrosis,

Taros Chemicals and Welab Barcelona partner for drug Discovery and development services

The combination will support clients in getting their end-to-end discovery and development programs delivered.

AnaBios acquires Cell Systems to expand human cell portfolio for drug discovery

Agilent presents 2023 Darlene Solomon Award to Kathryn Wolhuter

The award recognizes and supports promising female scientists working in mass spectrometry

Thermo Fisher Scientific opens cell therapy facility at University of California

The San Francisco facility is part of Thermo Fisher’s global pharma services network of more than 15 locations supporting cell and gene therapies.

Emmes acquires Essex Management

Essex enriches and complements Emmes’ services

Aptar appoints Julie Xing to its Board of Directors

Julie is recognized as a highly engaging multi-cultural leader skilled in fluidly partnering with cross-functional teams to deliver results.

ProBioGen’s growth strategy continues successfully

Julian Collins, Jana Windt and Michiel Stork join biopharma company’s leadership team